Syntroleum Corp  

(Public, NASDAQ:SYNM)   Watch this stock  
Find more results for SYNM
+0.14 (3.64%)
Apr 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.81 - 3.99
52 week 2.39 - 7.75
Open 3.89
Vol / Avg. 49,066.00/77,711.00
Mkt cap 39.74M
P/E     -
Div/yield     -
EPS -0.85
Shares 9.96M
Beta 2.14
Inst. own 30%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -2163.54% -441.70%
Operating margin -1128.88% -477.16%
EBITD margin - -467.96%
Return on average assets -43.41% -15.92%
Return on average equity -59.17% -22.43%
Employees 14 -
CDP Score - -


SUITE 400, 5416 S. YALE
TULSA, OK 74135
United States - Map
+1-918-5927900 (Phone)
+1-918-5927979 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Syntroleum Corporation (Syntroleum), along with its subsidiaries, is engaged in the commercialization of technologies to produce synthetic liquid hydrocarbons. The Syntroleum Technologies consist of air based syngas generation from natural gas, Fischer-Tropsch (FT) technology to convert syngas to FT wax, and hydroprocessing technology. The Company's hydro-processing technology is utilized either for conversion of FT wax (Synfining) or fats oils and greases (Bio-Synfining) into naphtha, diesel and liquefied petroleum gases (LPG). The Company also produces ASTM D7566, commercial jet fuel, as well as HRJ-5, military jet fuel. The Syntroleum Process produces synthetic liquid hydrocarbons that are substantially free of contaminants normally found in refined products made from crude oil. These synthetic liquid hydrocarbons can be further processed into fungible products through the Company's Synfining Process.

Officers and directors

Robert B. Rosene Jr. Independent Chairman of the Board
Age: 59
Bio & Compensation  - Reuters
Edward G. Roth President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Karen L. Power Principal Financial Officer, Senior Vice President
Age: 61
Bio & Compensation  - Reuters
Alvin R. Albe Jr. Independent Director
Age: 60
Bio & Compensation  - Reuters
Frank M. Bumstead Independent Director
Age: 71
Bio & Compensation  - Reuters
P. Anthony Jacobs Independent Director
Age: 71
Bio & Compensation  - Reuters
James R. Seward Independent Director
Age: 60
Bio & Compensation  - Reuters